Raymond James Financial Services Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-839
| Closed | -$17K | – | 3267 |
|
|
2022
Q3 | $17K | Sell |
839
-51
| -6% | -$1.03K | ﹤0.01% | 3154 |
|
|
2022
Q2 | $18K | Sell |
890
-114
| -11% | -$2.31K | ﹤0.01% | 3136 |
|
|
2022
Q1 | $43K | Buy |
1,004
+59
| +6% | +$2.53K | ﹤0.01% | 3179 |
|
|
2021
Q4 | $57K | Sell |
945
-598
| -39% | -$36.1K | ﹤0.01% | 3153 |
|
|
2021
Q3 | $133K | Sell |
1,543
-7
| -0.5% | -$603 | ﹤0.01% | 3068 |
|
|
2021
Q2 | $172K | Sell |
1,550
-183
| -11% | -$20.3K | ﹤0.01% | 3045 |
|
|
2021
Q1 | $193K | Sell |
1,733
-424
| -20% | -$47.2K | ﹤0.01% | 2907 |
|
|
2020
Q4 | $229K | Sell |
2,157
-2,559
| -54% | -$272K | ﹤0.01% | 2614 |
|
|
2020
Q3 | $656K | Buy |
4,716
+1,600
| +51% | +$223K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $1.01M | Buy |
3,116
+766
| +33% | +$248K | ﹤0.01% | 1485 |
|
|
2020
Q1 | $210K | Buy |
+2,350
| New | +$210K | ﹤0.01% | 2033 |
|